George Davis Snell NAS was an American mouse geneticist and basic transplant immunologist.
Rolf Martin Zinkernagel AC is a professor of experimental immunology at the University of Zurich. Along with Peter C. Doherty, he shared the 1996 Nobel Prize in Physiology or Medicine for the discovery of how the immune system recognizes virus-infected cells.
Thierry Boon is a Belgian scientist, former Director of the Ludwig Cancer Research branch in (Belgium) and professor at the Université Catholique de Louvain. He observed that tumour cells that have acquired new mutations as a result of mutagen treatment in vitro, often become incapable of forming tumours because they express new antigens recognized by the T cells of the immune system. His research allowed him to isolate the genes that code for these so-called tumour antigens. He is a member of the Cancer Research Institute Scientific Advisory Council, The National Academy of Sciences, and The Academy of Cancer Immunology.
Emil Raphael Unanue was a Cuban-American immunologist and Paul & Ellen Lacy Professor Emeritus at Washington University School of Medicine. He is a member of the National Academy of Sciences, the American Academy of Arts and Sciences and the Institute of Medicine. He previously served as chair of the National Academy of Sciences Section of Microbiology and Immunology.
Sir Philip Cohen is a distinguished British biochemist known for his extensive contributions to the field of biochemistry, especially to the understanding of the role of reversible protein phosphorylation in cell regulation.
Established in 1986, the Louis-Jeantet Prizes are funded by the Fondation Louis-Jeantet and awarded each year to experienced researchers who have distinguished themselves in the field of biomedical research in one of the member states of the Council of Europe. They are not intended solely as the recognition of work that has been completed, but also to encourage the continuation of innovative research projects. The prizes are awarded to fully active researchers whose scientific efforts are focused on biomedical research. When the research being recognised is close to practical applications for combating illnesses affecting humankind, one of the Louis-Jeantet Prizes converts into a Jeantet-Collen Prize for Translational Medicine, supported by generous donations from the Désiré Collen Stichting.
Philippa "Pippa" Marrack, FRS is an English immunologist and academic, based in the United States, best known for her research and discoveries pertaining to T cells. Marrack is the Ida and Cecil Green Professor and chair of the Department of Biomedical Research at National Jewish Health and a distinguished professor of immunology and microbiology at the University of Colorado Denver.
Nahum Sonenberg, is an Israeli Canadian microbiologist and biochemist. He is a James McGill professor of biochemistry at McGill University in Montreal, Quebec, Canada. He was an HHMI international research scholar from 1997 to 2011 and is now a senior international research scholar. He is best known for his seminal contributions to our understanding of translation, and notable for the discovery of the mRNA 5' cap-binding protein, eIF4E, the rate-limiting component of the eukaryotic translation apparatus.
Shizuo Akira is a professor at the Department of Host Defense, Osaka University, Japan. He has made ground-breaking discoveries in the field of immunology, most significantly in the area of innate host defense mechanisms.
Brigitte Alice Askonas was a British immunologist and a visiting professor at Imperial College London from 1995.
Philippe J. Sansonetti is a French microbiologist, professor at the Pasteur Institute and the Collège de France in Paris. He is the director of the Inserm Unit 786 and of the Institut Pasteur laboratory Pathogénie Microbienne Moléculaire.
Dame Fiona Magaret Powrie is currently the head of the Kennedy Institute of Rheumatology at the University of Oxford. Formerly she was the inaugural Sidney Truelove Professor of Gastroenterology at the University of Oxford. She is also head of the Experimental Medicine Division of the Nuffield Department of Clinical Medicine.
Sir Peter John Ratcliffe, FRS, FMedSci is a British physician-scientist who is trained as a nephrologist. He was a practising clinician at the John Radcliffe Hospital, Oxford and Nuffield Professor of Clinical Medicine and head of the Nuffield Department of Clinical Medicine at the University of Oxford from 2004 to 2016. He has been a Fellow of Magdalen College, Oxford since 2004. In 2016 he became Clinical Research Director at the Francis Crick Institute, retaining a position at Oxford as a member of the Ludwig Institute of Cancer Research and director of the Target Discovery Institute, University of Oxford.
Michael Nip Hall is an American-Swiss molecular biologist and professor at the Biozentrum of the University of Basel, Switzerland. He discovered TOR, a protein central for regulating cell growth.
Jérôme Galon is a French biologist. He is Director of Research of Exceptional Class (DRCE) at Institut National de la Santé et de la Recherche Médicale (INSERM). He is also an entrepreneur and co-founder of HalioDx.
Zelig Eshhar is an Israeli immunologist at the Weizmann Institute of Science and the Tel Aviv Sourasky Medical Center. He was Chairman of the Department of Immunology at the Weizmann Institute twice, in the 1990s and 2000s.
Jeffrey Victor Ravetch is a professor and head of the Laboratory of Molecular Genetics and Immunology at The Rockefeller University.
Shimon Sakaguchi is an immunologist and a Distinguished Professor of Osaka University. He is best known for the discovery of regulatory T cells and to describe their role in the immune system. This discovery is used in the treatment of cancer and autoimmune diseases.
Sir Andrew James McMichael, is an immunologist, Professor of Molecular Medicine, and previously Director of the Weatherall Institute of Molecular Medicine at the University of Oxford. He is particularly known for his work on T cell responses to viral infections such as influenza and HIV.
John Francis Xavier Diffley is an American biochemist and Associate Research Director at the Francis Crick Institute. He is known for his contributions to the understanding of how DNA replication is initiated, and how it is subsequently regulated throughout the cell cycle and in response to DNA damage.
